Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jantien J. Kettenes-van den Bosch"'
Publikováno v:
Macromolecular Rapid Communications. 20:577-581
N-isopropylacrylamide (NIPAAm) was copolymerized with 2-hydroxyethyl methacrylate-monolactate (HEMA-monolactate). With increasing HEMA-monolactate content in the copolymer, the lower critical solution temperature (LCST) decreases. During incubation i
Autor:
Albert J. R. Heck, Jennifer A. Kenny, Athene R.C. Smith, Martin Wills, Jantien J. Kettenes-van den Bosch
Publikováno v:
Tetrahedron: Asymmetry. 10:3267-3271
The synthesis of a class of macrocyclic receptors containing a phosphoramide is described. The preliminary evaluation of this new receptor for interactions with several homochiral amines using electrospray ionisation mass spectrometry is also describ
Autor:
Jantien J. Kettenes-van den Bosch, Roland E. C. Henrar, Olaf van Tellingen, Pablo Floriano, Jos H. Beijnen, Glynn Faircloth, Kenneth L. Rinehart, Bastiaan Nuyen, Jose Jimeno, Rolf W. Sparidans
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 729:43-53
A sensitive bio-analytical assay in plasma of the depsipeptide aplidine is reported, based on reversed-phase liquid chromatography and fluorescence detection of the trans-4'-hydrazino-2-stilbazole (4'H2S) derivative of the analyte. At ambient tempera
Autor:
Wijnand J. W. Schuyl, Petra van de Wetering, Jantien J. Kettenes-van den Bosch, Wim E. Hennink, Leon G. A. van de Water, Wendelmoed N. E. Van Dijk-Wolthuis, Mies J. van Steenbergen
Publikováno v:
Macromolecular Chemistry and Physics. 198:3893-3906
N-Carboxy-(N e -benzyloxycarbonyl)-L-lysine anhydride (Z-L-lysine NCA) was polymerized in dimethylformamide with triethylamine, diethylamine or hexylamine as initiator, at varying molar ratios of NCA to initiator (M/I ratio). After removal of the pro
Autor:
Jantien J. Kettenes-van den Bosch, Marnix A. Hoitink, Willy J. M. Underberg, Ed Hop, Auke Bult, Jos H. Beijnen
Publikováno v:
Journal of Chromatography A. 776:319-327
A capillary zone electrophoresis (CZE)–MS system for peptide analysis was developed, characterised and applied in the stability research of goserelin, a luteinising hormone-releasing hormone analogue. 10% acetic acid was used as running solution. A
Autor:
Wim E. Hennink, Jantien J. Kettenes-van den Bosch, Sylvia J. de Jong, Cornelus F. van Nostrum
Publikováno v:
ACS Symposium Series ISBN: 9780841238091
Advances in Controlled Drug Delivery: Science, Technology, and Products
Advances in Controlled Drug Delivery: Science, Technology, and Products
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42b68361c5972bab278632ca9b8f9e21
https://doi.org/10.1021/bk-2003-0846.ch010
https://doi.org/10.1021/bk-2003-0846.ch010
Autor:
Matthijs M. Tibben, Thomas Kerbusch, Jantien J. Kettenes-van den Bosch, Alwin D. R. Huitema, Sjoerd Rodenhuis, Jos H. Beijnen
Publikováno v:
Journal of chromatography. B, Biomedical sciences and applications. 745(2)
A simple and selective assay for the determination of the alkylating cyclophosphamide metabolite phosphoramide mustard (PM) in plasma was developed and validated. PM was determined after derivatisation by high-performance liquid chromatography (HPLC)
Autor:
Jantien J. Kettenes-van den Bosch, Cornelis Versluis, Jos H. Beijnen, Auke Bult, Olaf van Tellingen, Anneloes L. C. Sonneveldt, W. J. Nooijen
Publikováno v:
Cancer chemotherapy and pharmacology. 33(5)
We investigated the pharmacokinetics of the experimental semisynthetic vinca alkaloid vinleucinol (VileE; O4-deacetyl-3-de(methoxycarbonyl)-3-[[[1-ethoxycarbonyl-2- methylbutyl]amino]carbonyl]-vincaleukoblastine). The study was performed in male FVB
Autor:
Roland E. C. Henrar, Jantine D. Jonkman-de Vries, Marga J. A. de Graaff-Teulen, Auke Bult, Jantien J. Kettenes-van den Bosch, Jos H. Beijnen
Publikováno v:
Investigational new drugs. 12(4)
The aim of this study was to design a parenteral dosage form for the investigational cytotoxic drug carzelesin. A stable formulation in PET (Polyethylene glycol 400/absolute ethanol/Tween 80, 6:3:1, v/v/v) was developed. The prototype, containing 0.5
Autor:
Auke Bult, Jantien J. Kettenes-van den Bosch, Herre Talsma, Jantine D. Jonkman-de Vries, Roland E. C. Henrar, Jos H. Beijnen
Publikováno v:
Cancer chemotherapy and pharmacology. 34(5)
The aim of this study was to design a stable parenteral dosing form of the investigational cytotoxic drug, encoded EO9. EO9 exhibits poor aqueous solubility and stability characteristics. Freeze-drying was selected as the manufacturing process. Diffe